Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Biliary Tract Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    July 2018
  1. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
    Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
    Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
    PubMed     Text format    


    June 2018
  2. LI M, Liu F, Zhang F, Zhou W, et al
    Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
    Gut. 2018 Jun 28. pii: gutjnl-2018-316039. doi: 10.1136/gutjnl-2018-316039.
    PubMed     Text format     Abstract available


    April 2018
  3. JAHN D, Marzioni M, Geier A
    Manipulation of the gut-liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?
    Gut. 2018 Apr 20. pii: gutjnl-2018-316375. doi: 10.1136/gutjnl-2018-316375.
    PubMed     Text format    


  4. FUCHS CD, Paumgartner G, Mlitz V, Kunczer V, et al
    Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids.
    Gut. 2018 Apr 10. pii: gutjnl-2017-314553. doi: 10.1136/gutjnl-2017-314553.
    PubMed     Text format     Abstract available


  5. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Text format     Abstract available


    March 2018
  6. HIRSCHFIELD GM, Dyson JK, Alexander GJM, Chapman MH, et al
    The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
    Gut. 2018 Mar 28. pii: gutjnl-2017-315259. doi: 10.1136/gutjnl-2017-315259.
    PubMed     Text format     Abstract available


    August 2017
  7. ALBERTS R, de Vries EMG, Goode EC, Jiang X, et al
    Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
    Gut. 2017 Aug 4. pii: gutjnl-2016-313598. doi: 10.1136/gutjnl-2016-313598.
    PubMed     Text format     Abstract available


  8. JIAO N, Baker SS, Chapa-Rodriguez A, Liu W, et al
    Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Gut. 2017 Aug 3. pii: gutjnl-2017-314307. doi: 10.1136/gutjnl-2017-314307.
    PubMed     Text format     Abstract available


    July 2017
  9. DE VRIES EM, Wang J, Williamson KD, Leeflang MM, et al
    A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
    Gut. 2017 Jul 24. pii: gutjnl-2016-313681. doi: 10.1136/gutjnl-2016-313681.
    PubMed     Text format     Abstract available


  10. O'HARA SP, Karlsen TH, LaRusso NF
    Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
    Gut. 2017 Jul 21. pii: gutjnl-2017-314249. doi: 10.1136/gutjnl-2017-314249.
    PubMed     Text format    


    April 2017
  11. HUO X, Zhang X, Yu C, Cheng E, et al
    Aspirin prevents NF-kappaB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
    Gut. 2017 Apr 25. pii: gutjnl-2016-313584. doi: 10.1136/gutjnl-2016-313584.
    PubMed     Text format     Abstract available


  12. TRIVEDI PJ, Tickle J, Vesterhus MN, Eddowes PJ, et al
    Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.
    Gut. 2017 Apr 20. pii: gutjnl-2016-312354. doi: 10.1136/gutjnl-2016-312354.
    PubMed     Text format     Abstract available


    March 2017
  13. HANN A, Zizer E, Egger K, Allescher HD, et al
    Fatal outcome due to CO2 emboli during direct cholangioscopy.
    Gut. 2017 Mar 30. pii: gutjnl-2017-313988. doi: 10.1136/gutjnl-2017-313988.
    PubMed     Text format    


    February 2017
  14. TANG R, Wei Y, Li Y, Chen W, et al
    Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Gut. 2017 Feb 17. pii: gutjnl-2016-313332. doi: 10.1136/gutjnl-2016-313332.
    PubMed     Text format     Abstract available


  15. QURAISHI MN, Sergeant M, Kay G, Iqbal T, et al
    The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.
    Gut. 2017;66:386-388.
    PubMed     Text format    


    January 2017
  16. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Text format     Abstract available


    December 2016
  17. FERNANDEZ-BARRENA MG, Perugorria MJ, Banales JM
    Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis.
    Gut. 2016 Dec 16. pii: gutjnl-2016-312899. doi: 10.1136/gutjnl-2016-312899.
    PubMed     Text format    


    September 2016
  18. SINGH A, Smith PJ, Cropley IM, Planche KL, et al
    Gallstone mimicry: a rare cause of abdominal pain.
    Gut. 2016 Sep 29. pii: gutjnl-2016-312706. doi: 10.1136/gutjnl-2016-312706.
    PubMed     Text format    


  19. IWASAWA K, Suda W, Tsunoda T, Oikawa-Kawamoto M, et al
    Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312533. doi: 10.1136/gutjnl-2016-312533.
    PubMed     Text format    


  20. CAROTENUTO P, Fassan M, Pandolfo R, Lampis A, et al
    Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Gut. 2016 Sep 12. pii: gutjnl-2016-312278. doi: 10.1136/gutjnl-2016-312278.
    PubMed     Text format     Abstract available



  21. Erratum: Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice.
    Gut. 2016;65:1571.
    PubMed     Text format    


  22. RIZVI S, Yang JD, Gores GJ
    Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?
    Gut. 2016 Sep 1. pii: gutjnl-2016-312492. doi: 10.1136/gutjnl-2016-312492.
    PubMed     Text format    


    July 2016
  23. JENDREK ST, Gotthardt D, Nitzsche T, Widmann L, et al
    Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
    Gut. 2016 Jul 12. pii: gutjnl-2016-311739. doi: 10.1136/gutjnl-2016-311739.
    PubMed     Text format     Abstract available


  24. KARLSEN TH
    Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?
    Gut. 2016 Jul 11. pii: gutjnl-2016-312137. doi: 10.1136/gutjnl-2016-312137.
    PubMed     Text format    


    June 2016
  25. KUMMEN M, Hov JR
    Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Ruhlemann et al.
    Gut. 2016 Jun 23. pii: gutjnl-2016-312347. doi: 10.1136/gutjnl-2016-312347.
    PubMed     Text format    


    May 2016
  26. RUHLEMANN MC, Heinsen FA, Zenouzi R, Lieb W, et al
    Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.
    Gut. 2016 May 23. pii: gutjnl-2016-312180. doi: 10.1136/gutjnl-2016-312180.
    PubMed     Text format    


  27. SABINO J, Vieira-Silva S, Machiels K, Joossens M, et al
    Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Gut. 2016 May 20. pii: gutjnl-2015-311004. doi: 10.1136/gutjnl-2015-311004.
    PubMed     Text format     Abstract available


  28. DUPARC T, Plovier H, Marrachelli VG, Van Hul M, et al
    Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Gut. 2016 May 5. pii: gutjnl-2015-310904. doi: 10.1136/gutjnl-2015-310904.
    PubMed     Text format     Abstract available


    February 2016
  29. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.
    Gut. 2016 Feb 26. pii: gutjnl-2016-311452. doi: 10.1136/gutjnl-2016-311452.
    PubMed     Text format    


  30. KUMMEN M, Holm K, Anmarkrud JA, Nygard S, et al
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Gut. 2016 Feb 17. pii: gutjnl-2015-310500. doi: 10.1136/gutjnl-2015-310500.
    PubMed     Text format     Abstract available


    January 2016
  31. WALTER D, Teoh AY, Itoi T, Perez-Miranda M, et al
    EUS-guided gall bladder drainage with a lumen-apposing metal stent: a prospective long-term evaluation.
    Gut. 2016;65:6-8.
    PubMed     Text format    


    October 2015
  32. RODRIGUES CM, Moshage H
    Targeting TGR5 in cholangiocyte proliferation: default topic.
    Gut. 2015 Oct 28. pii: gutjnl-2015-310812. doi: 10.1136/gutjnl-2015-310812.
    PubMed     Text format    


    September 2015
  33. REICH M, Deutschmann K, Sommerfeld A, Klindt C, et al
    TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.
    Gut. 2015 Sep 29. pii: gutjnl-2015-309458. doi: 10.1136/gutjnl-2015-309458.
    PubMed     Text format     Abstract available


  34. BARON TH, Grimm IS
    Relief of obstructive jaundice from pancreatic cancer: the end of the plastic stent era?
    Gut. 2015 Sep 29. pii: gutjnl-2015-310519. doi: 10.1136/gutjnl-2015-310519.
    PubMed     Text format    


  35. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
    Gut. 2015 Sep 14. pii: gutjnl-2015-310593. doi: 10.1136/gutjnl-2015-310593.
    PubMed     Text format    


  36. VALENTIN N, Camilleri M, Altayar O, Vijayvargiya P, et al
    Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
    Gut. 2015 Sep 7. pii: gutjnl-2015-309889. doi: 10.1136/gutjnl-2015-309889.
    PubMed     Text format     Abstract available


    August 2015
  37. TOL JA, van Hooft JE, Timmer R, Kubben FJ, et al
    Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer.
    Gut. 2015 Aug 25. pii: gutjnl-2014-308762. doi: 10.1136/gutjnl-2014-308762.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: